The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review
- 31 August 1992
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 95 (2-3), 105-117
- https://doi.org/10.1016/0021-9150(92)90014-8
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Structural basis of latency in plasminogen activator inhibitor-1Nature, 1992
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989
- Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasmaFEBS Letters, 1988
- Impaired fibrinolysis in coronary artery diseaseAmerican Heart Journal, 1988
- Some recent advances in the chemistry and biology of transforming growth factor-beta.The Journal of cell biology, 1987
- DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein levelClinical Genetics, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Circadian Variation in the Frequency of Onset of Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Defective fibrinolysis in survivors of myocardial infarctionInternational Journal of Cardiology, 1984
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984